In summary, we demonstrated that the expression of EZH2 is up‐regulated in BC, the expression of DLC1 is down‐regulated in BC, and both up‐regulation of EZH2 and down‐regulation of DLC1 are correlated with poor prognosis in TNBC patients. The gene discussed is EZH2; the disease is breast cancer.